Nutritional Support

Baumgartner, Annic; Schüetz, Philipp

doi:10.1007/978-3-030-02278-5_24

Cited by 8 publications

(6 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Many centers (64%) used screening tools: >16% across EBMT and other centers [ 5 , 6 , 26 ]. To our knowledge, there is no standardized method for assessing nutritional status in children with cancer and those undergoing BMT [ 6 , [35] , [36] , [37] ]. Consequently, inconsistent strategies are widely used, each having limitations.…”

Section: Discussionmentioning

confidence: 99%

Nutritional support practices and opinions toward gastrostomy use in pediatric bone marrow transplant centers: A national survey

et al. 2022

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Nutritional support practices and opinions toward gastrostomy use in pediatric bone marrow transplant centers: A national survey

et al. 2022

View full text Add to dashboard Cite

“…In summary, assessment of nutritional status by an RD and consultation with a physiotherapist for rehabilitation are recommended during the diagnosis of hematological disease in transplant candidates. Interventions to improve pre-transplant nutritional status and performance status are crucial for improving clinical outcomes following allo-HSCT 31 .…”

Section: Pre-transplant Nutritional Supportmentioning

confidence: 99%

“…Nutritional support during this period is crucial for maintaining an adequately healthy nutritional status after allo-HSCT 3,32 . First, total caloric intake should be closely monitored, and when total caloric intake becomes insufficient, nutritional support should be implemented to maintain adequate total caloric intake to meet estimated needs 31,33 . The target total caloric intake can be determined using the Harris-Benedict formula or other formulas.…”

Section: Early Period After Allo-hsctmentioning

confidence: 99%

See 1 more Smart Citation

Nutritional support in allogeneic hematopoietic stem cell transplantation Asian perspective

Fuji

Cheng

Yakushijin

et al. 2022

BCT

View full text Add to dashboard Cite

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an integral part of the treatment strategy for patients with malignant or non-malignant hematological diseases. Clinical outcomes of patients undergoing allo-HSCT have significantly improved in recent decades. However, transplant-related morbidity and mortality remain major issues for allo-HSCT recipients.With regard to nutrition, patients undergoing allo-HSCT are at high risk for malnutrition. It is expected that clinical practice concerning nutritional support in allo-HSCT has been improving in recent decades; however, no data directly support this expectation. One major issue in managing nutritional support during allo-HSCT is the lack of large-scale randomized prospective studies, which leads to a lack of well-established strategies. Accordingly, we need to gather data from studies in non-HSCT and allo-HSCT settings. In some Asia-Pacific countries, a physician's lack of knowledge of nutritional support may impede the application of nutritional support practices recommended by existing guidelines. Another barrier may be the lack of access to an adequately qualified or trained registered dietitian (RD) at allo-HSCT units. Adequate training in the nutritional management of allo-HSCT patients should be provided to all RDs working with HSCT. Herein, we summarize the information on nutritional support in allo-HSCT, focusing on an Asian perspective.

show abstract

“…In neutropenic patients, e.g., following HSCT, the situation is complicated by restrictions of low-microbial diet primarily based on infectious safety of the nutrition with minimal contents of microorganisms (<500 CFU per 1 gram of meal) as proposed by several study groups [3,4]. However, there are no convincing data on proven efficiency of a low-microbial diet for prevention of infectious complications in the neutropenic patients [5,6].…”

Section: Introductionmentioning

confidence: 99%

Origin and consequences of intestinal dysfunction following cytostatic chemotherapy and hematopoietic stem cell transplantation

Goloshchapov,

Kucher,

Eismont

et al. 2023

CTT

View full text Add to dashboard Cite

The review article deals with pathogenesis and diagnostics of common gastrointestinal (GI) complications in patients with oncohematological diseases subjected to intensive chemotherapy and allogeneic hematopoietic stem cell transplantation (allo-HSCT). The associated GI disorders may present with hyporexia, nausea, vomiting, diarrhea, dehydration and intoxication thus causing protein-energy malnutrition and reducing efficiency of cancer therapeutics. The symptoms of intestinal dysfunction may develop early before HSCT due to cytostatic and antibacterial therapy. As a rule, it manifests with diarrhea caused by different reasons, e.g., antibiotic-associated bacterial dysbiosis, or enteropathogenic infections, impaired intestinal motility, or due to immune-mediated graft-versus-host disease (GvHD).

show abstract

Nutritional Support

Cited by 8 publications

References 20 publications

Nutritional support practices and opinions toward gastrostomy use in pediatric bone marrow transplant centers: A national survey

Nutritional support practices and opinions toward gastrostomy use in pediatric bone marrow transplant centers: A national survey

Nutritional support in allogeneic hematopoietic stem cell transplantation Asian perspective

Origin and consequences of intestinal dysfunction following cytostatic chemotherapy and hematopoietic stem cell transplantation

Contact Info

Product

Resources

About